Quick Take Asia

Asia Market Quick Take – 10 February, 2026

Macro 6 minutes to read
Saxo Be Invested
APAC Research

Asia Market Quick Take – 10 February, 2026

Key points:

  • Macro: US Inflation expectations drop to 3.1% from 3.4%
  • Equities: Dow notches another new high; Oracle gains 9.6% on upgrade
  • FX: Dollar weakened as G10 currencies rose; AUD and CHF outperformed
  • Commodities: Oil up for a second day; gold slipped after two-day gains
  • Fixed income: Alphabet raised $20bn in its largest-ever US dollar bond sale

------------------------------------------------------------------

qt 1002

Disclaimer: Past performance does not indicate future performance.

Macro: 

  • US one-year inflation expectations dropped to 3.1% from December's 3.4%. Slower rises are expected in gas, medical care, rent, and home prices. Three and five-year inflation expectations remain at 3%. Earnings growth rose to 2.7%, with unemployment at 41.9%.
  • Singapore raised its 2026 GDP growth forecast to 2-4%, up from 1-3%, due to continued AI-driven growth. Q4 GDP increased 6.9% year-on-year from AI-related electronics, pharmaceutical orders, and financial services, with 2025 growth at 5%, above the 4% forecast. The Ministry of Trade and Industry noted global economies outperformed expectations in Q4, 2025.
  • Fed Governor Miran supports a reduced central bank balance sheet but advisesmaintaining asset purchase options for downturns. Bloomberg highlighted his view that reducing the balance sheet won't hinder the Fed's crisis response, emphasizing the balance between reduction and policy flexibility.
  • Australia’s Consumer Sentiment Index fell 2.6% in February 2026 to a ten-month low of 90.5, following January's 1.7% dip, marking a third consecutive decline due to inflation worries and recent policy tightening after a 25bp rate hike.
  • Investors are cautious due to AI concerns and China's stance on US Treasury exposure. January inflation data, forecasted at 0.1%, is expected February 13. SNB Chairman Schlegel emphasized tackling low inflation at a 0% rate, focusing on a 0-2% target, with FX interventions possible if needed.

Equities:

  • US - US stocks advanced on Monday, with the Dow up 0.1% to a record high, the S&P 500 rising 0.5%, and the Nasdaq gaining 0.8%, supported by renewed strength in large‑cap tech and AI‑linked names. Chip and AI‑infrastructure stocks led the rebound, as Nvidia and Broadcom extended gains and Oracle surged 9.6% on an AI‑driven upgradeAlphabet raises $20b via senior unsecured notes that drew over $100b of demand.
  • EU - European equities opened the week higher, with the STOXX 50 up 0.9% and the STOXX 600 rising 0.5%, both hitting record highs. Sentiment followed global gains and a rally in Japan after Prime Minister Sanae Takaichi’s election victory. Healthcare outperformed, led by Novo Nordisk’s 8% jump and Novartis’ 0.9% rise after Hims & Hers withdrew its copycat weight‑loss drug. ASML, HSBC, AstraZeneca, SAP, and Rheinmetall also gained. UniCredit rose 5% on an upgraded profit outlook, while InPost surged over 13% on a takeover deal. Vinci slipped 1% and NatWest fell nearly 4%.
  • HK - Hang Seng jumped 467 points, or 1.8%, to 27,027 on Monday, rebounding from the prior session’s drop as all sectors advanced. Sentiment improved following Wall Street’s strong finish, with the Dow closing above 50,000 for the first time amid a chip‑stock rebound and hopes of further Fed easing. Mainland markets also strengthened after brokers encouraged investors to hold positions ahead of Lunar New Year. China’s forex reserves rose to USD 3.399 trillion, the highest since 2015. Gold‑related stocks gained on continued PBoC buying, while Innovent, Minth Group, and Meitu rallied on company‑specific catalysts.

Earnings this week:

  • Tuesday - Coca-Cola, CVS Health, Fiserv, Gilead Sciences, Ford, Spotify, Datadog, Upstart, Lyft, Robinhood, Honda
  • Wednesday - Cisco, Humana, Kraft Heinz, Albemarle, Shopify, Applovin, Unity, Vertiv, HubSpot, QuantumScape
  • Thursday - Brookfield, Pinterest, Arista, Rivian, Crocs, Coinbase, JFrog, Melco, Howmet Aerospace, Nebius, Softbank Group
  • Friday - Moderna, Enbridge, Cameco, Advance Auto Parts, Wendy’s

FX:

  • USD fell over 1% across two trading sessions following news that Chinese regulators advised financial institutions to reduce their holdings of US Treasuries. DXY fell below 97 level.
  • JPY strengthened against the USD following remarks from Japan’s top currency official about vigilance in the foreign exchange market.USDJPY dropped over 1% to a session low of 155.52 before slightly paring its decline.
  • GBP underperformed among G-10 currencies amid concerns over Prime Minister Keir Starmer's political future. GBPUSD rose 0.65% to 1.3698, maintaining above the 200-day moving average of 1.3432.
  • AUD outperformed against the USD, trading between a low of 0.7178 and a high of 0.7243, bolstered by positive risk sentiment and gains in precious metals. 
  • CHF also saw strong gains, trading below 0.7680 against USD, due to safe-haven demand amidst global uncertainties.

Commodities:

  • Gold slipped after two days of gains amid profit-taking in a choppy market seeking a floor after the historic rout, falling as much as 1.4% in early trade and briefly below $5,000, about 10% off its 29 Jan peak but still higher year to date.
  • Oil extended a two-day advance as Iran tensions added a risk premium; WTI held above $64 after a 1.7% two-session gain and Brent near $69, while the US warned US‑flagged ships to avoid Iranian waters in the Strait of Hormuz despite nuclear‑talk progress.

Fixed income:

  • US Treasuries firmed to start a pivotal week, with yields about 1bp lower and the 10-year near 4.2% as traders await labour and inflation data; the front end and belly outperformed after NEC Director Kevin Hassett flagged potential labour-market softening, while an early steepening faded amid anticipation of Alphabet’s $20bn jumbo—part of $23.8bn in dollar supply.

For a global look at markets – go to Inspiration.

This content is marketing content and should not be considered investment advice. Trading financial instruments carries risks and historic performance is not a guarantee for future performance.The instrument(s) mentioned in this content may be issued by a partner, from which Saxo receives promotion, payment or retrocessions. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

 

Quarterly Outlook

01 /

  • Q1 Outlook for Traders: Five Big Questions and Three Grey Swans.

    Quarterly Outlook

    Q1 Outlook for Traders: Five Big Questions and Three Grey Swans.

    John J. Hardy

    Global Head of Macro Strategy

    Strap yourself in for key market questions that must be answered in 2026.
  • Q1 Outlook for Investors: “AI” party hangover needs discipline and diversification

    Quarterly Outlook

    Q1 Outlook for Investors: “AI” party hangover needs discipline and diversification

    Charu Chanana

    Chief Investment Strategist

    2026 is a high-valuation, high-dispersion year: the AI story matures, policy becomes less predictabl...
  • Q4 Outlook for Investors: Diversify like it’s 2025 – don’t fall for déjà vu

    Quarterly Outlook

    Q4 Outlook for Investors: Diversify like it’s 2025 – don’t fall for déjà vu

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Q4 Outlook for Traders: The Fed is back in easing mode. Is this time different?

    Quarterly Outlook

    Q4 Outlook for Traders: The Fed is back in easing mode. Is this time different?

    John J. Hardy

    Global Head of Macro Strategy

    The Fed launched a new easing cycle in late Q3. Will this cycle now play out like 2000 or 2007?
  • Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Quarterly Outlook

    Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    Quarterly Outlook

    Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    John J. Hardy

    Global Head of Macro Strategy

    After the chaos of Q2, the quarter ahead should get a bit more clarity on how Trump 2.0 is impacting...
  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.


Hong Kong

Contact Saxo

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.